top of page

Flashpoint - Edition #20

This week’s best performer grabbed the top spot after taking on big pharma and winning, the power of a green leaf also beat out some green energy players, turning heads in critical minerals.




FLASHPOINT - TRANSCRIPT


Tim - Here's Matt Birney with the ASX Runners of the Week.


Tim - Thanks to Argonaut


Matt Birney - Thanks Tim.


Matt Birney - Well Zelira Therapeutics was this week’s big runner, charging more than 256 per cent after its diabetic nerve pain drug was found to outperform an equivalent product from big pharma.


Matt Birney - Its shares powered on to hit $3.35 this week after closing last week at 94.


Matt Birney - Solis Minerals bolted 221 per cent after signing an agreement to snare the Jaguar lithium project in Brazil. That play saw its stock run from 14 to 45 cents.


Matt Birney - Software company Webcentral also had a big week after an investment fund picked up 5 per cent of the company, causing its shares to take a run from 6.9 to 17.5 cents, a healthy hike of 154 per cent.


Matt Birney - And finally Reach Resources doubled from 0.6 to 1.2 cents on the back of its latest heavy rare earths samples from WA’s Gascoyne region that also contained high-grade niobium.


Matt Birney - And with the lucrative metal selling for around $50,000 US dollars a tonne, that little find is sure to quicken a few pulses – just like it did for WA1 Resources in October last year.



9 views

Recent Posts

See All

Comments


bottom of page